ImmuCell Corporation (FRA:IUL)

ImmuCell Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	37	44	36	44	54	35
Market Cap Growth	23.99%	24.20%	-19.28%	-18.81%	55.23%	6.04%
Enterprise Value	45	56	49	48	54	39
Last Close Price	4.16	4.72	4.42	5.65	7.50	5.05
PE Ratio	18.62	-	-	-	-	-
PS Ratio	1.56	1.73	2.26	2.55	3.22	2.80
PB Ratio	1.45	1.67	1.58	1.56	1.90	1.52
P/TBV Ratio	1.46	1.68	1.59	1.56	1.91	1.53
P/FCF Ratio	60.49	-	-	-	-	-
P/OCF Ratio	21.75	128.23	-	-	64.91	32.62
EV/Sales Ratio	1.89	2.17	3.10	2.76	3.22	3.13
EV/EBITDA Ratio	8.86	39.63	-	65.78	22.78	49.62
EV/EBIT Ratio	19.23	-	-	-	240.62	-
EV/FCF Ratio	74.21	-	-	-	-	-
Debt / Equity Ratio	0.46	0.55	0.67	0.41	0.32	0.38
Debt / EBITDA Ratio	2.29	7.75	-	12.96	3.57	9.69
Debt / FCF Ratio	19.02	-	-	-	-	-
Asset Turnover	0.62	0.60	0.39	0.42	0.45	0.39
Inventory Turnover	1.85	2.43	1.89	2.26	4.09	3.68
Quick Ratio	1.63	1.72	0.76	2.47	5.09	4.44
Current Ratio	4.21	3.41	2.73	4.56	6.42	5.50
Return on Equity (ROE)	8.27%	-8.21%	-20.86%	-7.92%	-0.26%	-3.57%
Return on Assets (ROA)	3.79%	-1.73%	-7.36%	-2.39%	0.38%	-2.18%
Return on Capital (ROIC)	4.01%	-1.83%	-7.72%	-2.49%	0.39%	-2.26%
Return on Capital Employed (ROCE)	6.60%	-3.00%	-13.20%	-4.10%	0.60%	-3.60%
Earnings Yield	5.37%	-4.70%	-14.64%	-5.28%	-0.13%	-2.38%
FCF Yield	1.65%	-0.24%	-16.64%	-11.68%	-2.67%	-6.42%
Buyback Yield / Dilution	-14.38%	-5.42%	-0.03%	-2.01%	-5.25%	-5.78%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.